Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
Alteplase is a recombinant form of human tissue plasminogen activator (tPA) that converts plasminogen to plasmin essential for fibrinolysis. It is commonly used to treat embolic or thrombotic disorders such as ischemic stroke. Despite its rarity use in ophthalmology, we are reporting the effectiv...
Saved in:
Main Authors: | Siti Noor Atikah AR,, Safinaz Mohd Khialdin,, Mushawiahti Mustapha,, Muhammad Syamil MS,, Ayesha MZ, |
---|---|
Format: | Article |
Language: | English |
Published: |
Pusat Perubatan Universiti Kebangsaan Malaysia
2022
|
Online Access: | http://journalarticle.ukm.my/19680/1/24_ms0517_pdf_18838.pdf http://journalarticle.ukm.my/19680/ https://www.medicineandhealthukm.com/toc/17/1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
by: AR, Siti Noor Atikah, et al.
Published: (2022) -
Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2012) -
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Al-Hamodi, Z., et al.
Published: (2011) -
Pupillary Behavior in Positive and Negative Emotions
by: Babiker, Areej, et al.
Published: (2013) -
The association between serum and tear plasminogen activator inhibitor-1 and tissue plasminogen activator in patients with diabetic retinopathy / Nurbadriah Jasmiad
by: Jasmiad, Nurbadriah
Published: (2021)